Artelo Biosciences, Inc. Warrant
ARTLW
ARTLW was delisted on the 17th of June, 2024.
2 hedge funds and large institutions have $85K invested in Artelo Biosciences, Inc. Warrant in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$56.7K |
| 2 |
Verition Fund Management
Greenwich,
Connecticut
|
+$30.5K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CH
1
CVI Holdings
Wilmington,
Delaware
| $55K | +$56.7K | +65,000 | New |
|
|
2
Verition Fund Management
Greenwich,
Connecticut
| $30K | +$30.5K | +35,000 | New |
|
ARTLW Hedge Fund Activity: Q2 2019 in Review
2 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences, Inc. Warrant (ARTLW) for Q2 2019, worth a combined $85K.
Buyers outnumbered sellers: 2 funds opened new ARTLW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was CVI Holdings, opening a new position worth an estimated $56.7K.
- 2 institutional investors held Artelo Biosciences, Inc. Warrant (ARTLW) as of Q2 2019, up from 0 in Q1 2019.
- Funds reported $85K of Artelo Biosciences, Inc. Warrant stock for Q2 2019.
- 2 funds opened new Artelo Biosciences, Inc. Warrant positions in Q2 2019 and 0 closed out, a net change of +2 holders.
- The largest Artelo Biosciences, Inc. Warrant buyer in Q2 2019 was CVI Holdings, an estimated $56.7K added.
Based on aggregated 13F filings for Q2 2019.